JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on July 15, 2005; DOI: 10.1124/jpet.105.086694


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.105.086694v1
315/1/458    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Larsson, A.-K.
Right arrow Articles by Dahlen, S.-E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Larsson, A.-K.
Right arrow Articles by Dahlen, S.-E.


Received for publication April 6, 2005.
Revised June 17, 2005.
Accepted for publication July 13, 2005.

Inhibition of NOS enhances antigen-induced contractions and increases release of cysteinyl-leukotrienes in guinea pig lung parenchyma: NO as a protective factor

Anna-Karin Larsson 1*, Magnus Back 1, Josephine Hjoberg 1, Sven-Erik Dahlen 1

1 Karolinska Institutet

* Address correspondence to: E-mail: anna-karin.larsson{at}imm.ki.se

Abstract

Nitric Oxide (NO) in exhaled air is a biomarker of airway inflammation. However, the role of NO in the peripheral lung is not known. The aim of this study was to determine the role of endogenous NO in antigen-induced contractions of ovalbumin (OVA)-sensitized guinea pig lung parenchyma (GPLP). The contraction in this in vitro model of the peripheral lung closely resembles the corresponding response in human airways. Cumulatively increasing concentrations (10-10,000 µg/L) of ovalbumin (OVA) induced concentration-dependent contractions of the GPLP that were enhanced by the nitric oxide synthase (NOS) inhibitors N{omega}-nitro-L-arginine (L-NOARG, 100 µM) N{omega}-monomethyl-L-arginine (L-NMMA, 100 µM), N{omega}-Nitro-L-arginine Methyl Ester (L-NAME, 100 µM) and 1400W (1 µM). The enhancement induced by L-NOARG was reversed by co-administration with the 5-lipoxygenase inhibitor BAYx1005 (3 µM), whereas co-administration of L-NOARG with the cyclooxygenase inhibitor indomethacin (10 µM) did not change the effect of L-NOARG alone. L-NOARG (100 µM) did not affect the cumulative concentration response relations for either leukotriene (LT) D4 (0.1-100 nM) or histamine (1-30 µM). The NO donor NONOate (0.001-100 µM) was ineffective in GPLP but potently relaxed precontracted guinea-pig pulmonary artery. Furthermore, L-NOARG enhanced the release of LTE4 and decreased the release of prostaglandin E2 induced by OVA. In conclusion, endogenous NO exerts an inhibitory effect on antigen-induced contractions in the peripheral lung. The action of NO apparently involves inhibition of the release of mediators, rather than direct relaxation of airway smooth muscle. The findings support that NO is a protective anti-inflammatory factor.


Key words: airway smooth muscle, antigen-induced, guinea pig lung parenchyma, leukotrienes, nitric oxide, prostaglandins


This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
H. Maarsingh, A. B. Zuidhof, I. S. T. Bos, M. van Duin, J.-L. Boucher, J. Zaagsma, and H. Meurs
Arginase Inhibition Protects against Allergen-induced Airway Obstruction, Hyperresponsiveness, and Inflammation
Am. J. Respir. Crit. Care Med., September 15, 2008; 178(6): 565 - 573.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
P. Nieri, C. Martinelli, C. Blandizzi, N. Bernardini, R. Greco, C. Ippolito, M. Del Tacca, and M. C. Breschi
Role of Cyclooxygenase Isoforms and Nitric-Oxide Synthase in the Modulation of Tracheal Motor Responsiveness in Normal and Antigen-Sensitized Guinea Pigs
J. Pharmacol. Exp. Ther., November 1, 2006; 319(2): 648 - 656.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
E. Ihre, P. Gyllfors, L. E. Gustafsson, M. Kumlin, and B. Dahlen
Early rise in exhaled nitric oxide and mast cell activation in repeated low-dose allergen challenge
Eur. Respir. J., June 1, 2006; 27(6): 1152 - 1159.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics.